OTHER INFORMATION
+Added: 10.1# Form of Time-Based Restricted Stock Unit Award Agreement under the 2017 IPO Stock Incentive Plan
+Added: 10.2# Form of Performance-Based Restricted Stock Unit Award Agreement under the 2017 IPO Stock Incentive Plan
31.1 Certification of Periodic Report by Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002.
3 unchanged sentences
101 Inline XBRL (Extensible Business Reporting Language).
−Removed: The following materials from this Quarterly Report on Form 10-Q for the period ended September 30, 2022, are formatted in Inline XBRL:
+Added: The following materials from this Quarterly Report on Form 10-Q for the period ended March 31, 2023, are formatted in Inline XBRL:
(i) consolidated balance sheets of Krystal Biotech, Inc., (ii) consolidated statements of operations of Krystal Biotech, Inc., (iii) consolidated statements of comprehensive income/(loss) of Krystal Biotech, Inc., (iv) consolidated statements of changes in equity of Krystal Biotech, Inc., (v) consolidated statements of cash flows of Krystal Biotech, Inc.
2 unchanged sentences
104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL.
+Added: # Indicates a management contract or compensatory plan or arrangement.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
KRYSTAL BIOTECH, INC.
−Removed: November 7, 2022
President and Chief Executive Officer
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.